Poland· PL-100251029
Astmodil
A montelukast product containing montelukastum, registered in Poland by Polfarmex S.A.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Montelukast is registered in 19 of 19 countries.
Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Montelukast · ATC R03DC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of montelukast costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Montelukast · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$1.71
- CH Switzerland$1.41
- FR France$0.71
- IT Italy$0.59
The record
At a glance
URPL (Poland)- Active substance
- Montelukastum
- Manufacturer
- Polfarmex S.A.
- Country
- Poland (PL)
- ATC code
- R03DC03
- ATC class
- Montelukast
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
1 priced- gtin0590999142246228 szt.PLN 27.12
- gtin05909990881697
- gtin05909990881703
- gtin05909990881727
- gtin05909990881734
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
565 interactions on record for montelukast.
Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Montelukast · interactions on record
565 records
- 101 moderate
- 464 info
Most severe, free to view
- MiconazoleA07AC01moderate
- TroglitazoneA10BG01moderate
- NateglinideA10BX03moderate
- NitisinoneA16AX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Montelukast in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCASTISPIRSandoz s.r.o., Praha
- SpainMONKASTA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- United StatesMontelukastXLCare Pharmaceuticals Inc.
- ItalyELUNKASTPIAM FARMACEUTICI S.P.A.
- BelgiumMontelukast AB 10 mgAurobindo Pharma
- FinlandAirathonN.V. Organon
- FranceMONTELUKAST ACCORD HEALTHCARE 10 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- NetherlandsMontelukast 10 mg Teva, filmomhulde tablettenTeva Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lanair, Montelukast +pharma
- Belgium · Montelukast Ab, Montelukast Eg
- Bulgaria · Eфира, Moнтелукаст Акорд
- Cyprus · Modulair, Montelukast Krka
- Czechia · Castispir, Monkasta
- Germany · Monkasta, Montelair Hexal
- Denmark · Montelukast "sandoz", Montelukast Accord Healthcare
- Estonia · Monkasta, Montelukast Teva
- Spain · Monkasta, Montelukast Accord
- Finland · Montelukast, Montelukast Accord
- France · Montelukast Accord, Montelukast Accord Healthcare
- United Kingdom (Northern Ireland) · Montelukast, Montelukast for Children From 6 To 14 Years Accord Healthcare
- Greece · Apilone, Ascolin
- Croatia · Melarth, Monkasta
- Hungary · Eonic, Monalux
- Ireland · Montelair, Montelukast
- Iceland · Montelukast Alvogen, Singulair
- Italy · Aleast Per Bambini Da 2 A 5 Anni, Aleast Per Bambini Da 6 A 14 Anni
- Lithuania · Monkasta
- Luxembourg · Montelukast Eurogenerics, Montelukast Ratiopharm
- Latvia · Monkasta
- Malta · Actamone, Monkasta
- Netherlands · Montelukast Accord, Montelukast Amarox
- Norway · Montelukast Krka, Montelukast Sandoz
- Portugal · Montelucaste Accord, Montelucaste Alter
- Romania · Monkasta, Montelukast Arena
- Sweden · Montelukast Accord, Montelukast Amarox
- Slovenia · Monkasta, Singulair
- Slovakia · Astmasan, Belokast
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdef73cf-7944-4ba5-b9f2-1e19e45cb0b8 GET /v1/drugs/cdef73cf-7944-4ba5-b9f2-1e19e45cb0b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909990881697 ¦ Rp ¦ Skasowane ¦ 67611\n14 tabl. w blistrze\n05909990881703 ¦ Rp ¦ Skasowane ¦ 67612\n14 tabl. w pojemniku\n05909990881727 ¦ Rp ¦ Skasowane ¦ 67613\n28 tabl. w blistrze\n05909990881734 ¦ Rp ¦ 67614\n1 poj. 28 tabl.\n05909991422462 ¦ Rp ¦ 135236\n28 tabl. w blistrze",
"substance": "Montelukastum natricum 10 mg",
"common_name": "Montelukastum",
"pl_product_id": "100251029",
"pozwolenie_nr": "18412",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about montelukast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.